INOSTICS is now SYSMEX INOSTICS
Inostics GmbH is pleased to announce that we have been acquired by Sysmex. Effective Oct 1st, Inostics operates as “Sysmex Inostics”, a subsidiary of Sysmex Corporate. The acquisition is designed to expand and intensify the current portfolio for research and clinical diagnostic services based on Inostics’ technology as well as our companion diagnostic IVD development offerings.
The official press release is available here.
Our DNA blood tests provide precise insight into the genetics of solid tumors. This is accomplished with our highly sensitive BEAMing Digital PCR and sequencing technologies. With a liquid biopsy, treatment decisions can now be made with the right information at any time. Non-invasive. Sensitive. Real-time.
SENSITIVE MUTATION DETECTION
OncoBEAM – Single Gene Testing
OncoBEAM – Multigene Testing